Charts

25 Sep, 2022

News

13 Sep, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a ...
12 Sep, 2022
Gainers Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 61.0% to $37.18 during Monday's regular session. ...
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating ...
07 Sep, 2022
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will participate in a fireside chat at the Baird 2022 Global Healthcare Conference, being held in New York on September 13-14, 2022.
06 Sep, 2022
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the appointment of Richard L. Schilsky, MD, FASCO, FACP, FSCT to its Board of Directors, effective September 1, 2022. Dr. Schilsky brings over 40 years of experience in medicine and clinical research, specializing in new drug development and clinical trials for a wide range of cancers.
04 Sep, 2022
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Company will be presenting data in first-line patients with advanced gastroesophageal adenocarcinoma (GEA) from the DisTinGuish study, a Phase 2a clinical trial evaluating Leap's anti-Dickkopf-1 (DKK1) antibody, DKN-01, in combination with tislelizumab, BeiGene's anti-PD-1 antibody, and chemotherapy, at the European Society for Medical Oncology (ESM
12 Aug, 2022
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics today announced that its Board member, Monica Bertagnolli, MD, has been appointed as the 16th Director of the National Cancer Institute (NCI) by the Biden administration. Dr. Bertagnolli becomes the first woman director of the institute since its inception in 1937. Effective with her appointment, Dr. Bertagnolli will transition off Leap's Board of Directors.
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2022.
21 Jul, 2022
If you want to know who really controls Leap Therapeutics, Inc. ( NASDAQ:LPTX ), then you'll have to look at the makeup...
14 Jul, 2022
The NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in hospitalized COVID-19 patients fails to meet the primary endpoint. Stock down.
The FDA bestows an Orphan Drug designation to Amryt's (AMYT) Mycapssa for the treatment of carcinoid syndrome. Stock up in pre-market trading.
12 Jul, 2022
The FDA's potential approval of Perrigo (PRGO) unit, HRA Pharma's OTC birth control pills can make the drug the first of its kind to be made available without prescription in the United States.
Novo Nordisk's (NVO) phase I & II FRONTIER1 dose-escalation study investigating Mim8 for treating people with haemophilia A meets its primary safety endpoint.
Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and acc688235ess for patients worldwide, today announced the initiation of Part C of the ongoing DisTinGuish study to evaluate DKN-01, Leap's anti-SSEDickkopf 1 (DKK1) antibody
11 Jul, 2022
The FDA approves Horizon's (HZNP) sBLA for Krystexxa injection plus methotrexate to help people suffering from uncontrolled gout achieve a complete response to therapy.
Boot Barn, Canada Goose, Pediatrix Medical Group, Leap Therapeutics, and Oncolytics Biotech are part of Zacks Screen of the week article.
08 Jul, 2022
Editas' (EDIT) lead pipeline candidate, EDIT-101, which employs CRISPR gene editing to treat LCA10, holds potential. Dependence on partners for collaboration revenues a woe.
The recent setback faced by Acadia's (ACAD) resubmitted sNDA for Nuplazid (pimavanserin) for treating hallucinations and delusions associated with ADP has hurt the stock.
07 Jul, 2022
Adverum (ADVM) completes IND amendment with the FDA for initiating the phase II LUNA study on its gene therapy candidate, ADVM-022, for treating wet-age-related macular degeneration. Stock up.
04 Jul, 2022
Celldex (CLDX) posts interim data from the phase Ib study evaluating barzolvolimab in patients with moderate to severe chronic spontaneous urticaria. Shares down.
29 Jun, 2022
Seagen (SGEN) is riding on the strong uptake of its marketed drugs that are approved for different cancer indications. Further label expansion of these drugs should boost the top line.
Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the company. Shares rise.
28 Jun, 2022
Cybin (CYBN) receives a "may proceed letter" and IND application clearance from the FDA for a phase I/IIa study evaluating CYB003 for potential treatment of major depressive disorder. Shares up.
31 May, 2022
Gainers Performance Shipping Inc. (NASDAQ: PSHG) rose 41.7% to $ 0.94 in pre-market trading. Performance Shipping shares dipped ...
16 May, 2022
09:23
FinancialContent
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend ...
13 May, 2022
20 Apr, 2022
09:43
FinancialContent
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron ...
11 Mar, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of ...
Leap Therapeutics (NASDAQ:LPTX) reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM. Here's what ...
18 Feb, 2022
04 Feb, 2022
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market ...
21 Jan, 2022
09:29
FinancialContent
Gainers Aptorum Group Limited(NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company ...
19 Jan, 2022
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock rose 6.7% to $1.92 during Wednesday's after-market session. The company's market cap ...
Positive clinical trial results are giving investors a reason to cheer.
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for ...
These clinical-stage biotech stocks are headed in opposite directions today.
Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...
Leap Therapeutics Inc(NASDAQ: LPTX) will presentupdated data from the DisTinGuish Phase 2a study of DKN-01, in combination ...
16 Jan, 2022
These two biotech stocks are set to report key clinical data later this year.
15 Oct, 2021
Investors in Leap Therapeutics Inc (LPTX) saw new options begin trading this week, for the June 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
14 Oct, 2021
14:00
FinancialContent
These two tiny drugmakers might be hidden gems.
13 Oct, 2021
05 Oct, 2021
Find out why last month was a big one for these three drugmakers.
04 Oct, 2021
Upgrades According to Raymond James, the prior rating for Roper Technologies Inc (NYSE:ROP) was changed from Outperform ...
01 Oct, 2021
Benzinga Pro data, Leap Therapeutics (NASDAQ:LPTX) reported Q2 sales of $375.00 thousand. Earnings fell to a loss of $9.63 million, ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...
08:44
FinancialContent
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on ...
29 Sep, 2021
12:13
FinancialContent
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
23 Sep, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
22 Sep, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 70.1% to $9.68 in pre-market trading following an announcement from ...
21 Sep, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular ...
17 Sep, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) shares moved upwards by 8.27% to $5.76 during Friday's after-market session. This ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There's only one day of trading left so let's start it off right with a look at the biggest pre-market stock movers for Friday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
16 Sep, 2021
Leap Therapeutics(NASDAQ:LPTX)shares are trading higher after the company announced it presented updated results for its ...
Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ForgeRock (FORG) stock is on the move Thursday afternoon following the company's successful initial public offering (IPO). The post ForgeRock IPO: 12 Things for Potential Investors to Know as FORG Stock Debuts appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Space stocks are taking off on Thursday and it's all thanks to Elon Musk's SpaceX reaching a major milestone for commercial space travel. The post Space Stocks: Why SPIR, ASTR, MNTS, RDW and SPCE Are Getting a Boost Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As ...
Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Luokung Technology (LKCO) stock is revving up on Thursday after revealing a deal with Microsoft (MSFT) that has investors excited. The post LKCO, MSFT: The Big Autonomous Driving News Revving Up Luokung Technology Stock Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Leap Therapeutics (LPTX) stock is on the move today following an update from the biotechnology company for recent clinical trial results. The post LPTX Stock: What Leap Therapeutics Investors Are Clicking Their Heels About Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Leap Therapeutics Inc(NASDAQ: LPTX) announcedupdated data from the first-line cohortof the DisTinGuish Phase 2a ...
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as ...
15 Sep, 2021
13 Aug, 2021
14 May, 2021
12 Mar, 2021
06 Nov, 2020
20:30
Seeking Alpha

Related Articles